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This year, the Albert Lasker Basic Medical Research Award will be shared by Richard Scheller and
Thomas Su¨dhof for their elucidation of the molecular mechanisms underlying neurotransmitter
release. Their discoveries provided insight into the molecular basis of synaptic transmission and
enhanced our understanding of how synaptic dysfunction may cause neuropsychiatric disorders.Hitting a fastball, writing a symphony, or
simply pulling fingers off a hot plate in a
timely fashion all depend on neuron-to-
neuron and neuron-to-muscle communi-
cation that happens simultaneously atmil-
lions of synapses throughout the central
and peripheral nervous systems. Indeed,
chemical synaptic transmission has been
conserved through the millions of years
that it has taken the brains of primitive
organisms such as flies and worms to
evolve into the 3-pound organ sitting in
our heads. The seminal work of pioneers
including Otto Loewi and Sir Henry Dale
(who shared the 1936Nobel Prize in Phys-
iology or Medicine) and Sir John Eccles
(1963 Nobel Prize in Physiology or
Medicine) established that presynaptic
neurons release chemical messengers
(neurotransmitters) that, depending on
their identity, can either excite or inhibit
postsynaptic targets, including muscles
and other neurons. Working at the neuro-
muscular junction, Sir Bernard Katz
(1970 Nobel Prize in Physiology or Medi-
cine) made the critical observation that
neurotransmitters are released in pre-
assembled multimolecular packages
termed ‘‘quanta’’ and that the very rapid
action potential-evoked release of neuro-
transmitter quanta is triggered by calcium
that enters presynaptic nerve terminals
when an action potential opens voltage-
gated calcium channels. The quantal
nature of chemical synaptic transmission
was confirmed by electron microscopic
images showing that presynaptic termi-
nals are full of tens to hundreds of small
uniform vesicles, the perfect containers
for neurotransmitter quanta (Figure 1A).These pioneering studies established
that the presynaptic release machinery
evolved to achieve the critical goal of
very rapid triggering of neurotransmitter
release at the right place (synapses) and
at precisely the right time, when an action
potential invades the presynaptic termi-
nal. For many decades, however, the
molecular machinery responsible for the
exquisite calcium-dependent control of
neurotransmitter release was unknown.
Richard Scheller and Thomas Su¨dhof
receive this year’s Basic Medical
Research Award from the Albert Lasker
Foundation for their brilliant elucidation
of the key molecular machinery and regu-
latory mechanisms that underlie the rapid
release of neurotransmitter. Their efforts
led to an exquisitely detailed picture of
the molecular interactions underlying pre-
synaptic vesicle fusion with the presynap-
tic plasma membrane and revealed how
this fusion event is tightly regulated,
such that it is rapidly triggered by the
influx of calcium during an action poten-
tial. Their elucidation of this fundamental
property of all chemical synapses in prim-
itive and advanced nervous systems alike
opened the flood gates to a detailed
molecular understanding of synaptic
function. As a consequence, we have
gained insight into the molecular under-
pinnings of the brain’s amazing functions
and the molecular pathophysiology of
devastating neuropsychiatric disorders.
The First Critical Step
Scheller and Su¨dhof came at the problem
of the molecular mechanisms underlying
neurotransmitter release from differentCell 154, Sepyet related backgrounds. Both completed
successful postdocs with Nobel laure-
ates. Working with Richard Axel (2004
Nobel Prize in Physiology or Medicine)
and Eric Kandel (2000 Nobel Prize in
Physiology or Medicine), Scheller cloned
genes encoding neuropeptides important
for controlling behaviors in Aplysia, a clear
indication of his long-standing interest in
fundamental neurobiology topics. Su¨d-
hof, working with Michael Brown and
Joseph Goldstein (1985 Nobel Prize in
Physiology or Medicine), cloned the LDL
receptor gene and elucidated its regula-
tion by cholesterol. In addition to this
important foray into lipid biology, Su¨dhof
had a long-standing interest in neuro-
transmitter release mechanisms em-
anating from his medical school research
with Victor Whittaker who, 50 years ago,
first biochemically isolated presynaptic
vesicles. Upon embarking on their inde-
pendent research careers, both Scheller
and Su¨dhof were convinced that they
could use biochemical techniques to
systematically purify the protein constitu-
ents of presynaptic vesicles and their in-
teracting partners, clone them, and then
elucidate their functions using cell biolog-
ical, genetic, and physiological tech-
niques. Because of their efforts and those
of collaborators such as Reinhard Jahn,
the presynaptic vesicle has become the
best characterized cellular organelle in
mammalian biology.
The first synaptic vesicle protein to be
isolated and cloned was synaptophysin,
but as luck would have it, despite major
efforts, the function of synpatophysin re-
mains enigmatic. Within a year of eachtember 12, 2013 ª2013 Elsevier Inc. 1171
Figure 1. Neurotransmitter Release Mechanisms
(A) Electron micrograph of a presynaptic terminal showing a population of uniform presynaptic vesicles, some of which are ‘‘docked’’ at the presynaptic plasma
membrane.
(B) Diagram showing the key molecules that mediated neurotransmitter release: the three key SNARE proteins (synaptobrevin/VAMP, synatxin, and SNAP-25),
Munc18, complexin, and synaptotagmin.other, Scheller, using cholinergic vesicles
from the electric organ of Torpedo, and
Su¨dhof and Jahn, using rat brain pre-
synaptic vesicles, cloned the synaptic
vesicle membrane protein synaptobre-
vin/VAMP-1 (Trimble et al., 1988; Su¨dhof
et al., 1989). This was fortuitous because
synaptobrevin/VAMP-1 turned out to be
a ‘‘v-SNARE,’’ one of the three critical
components of SNARE protein-mediated
membrane fusion, a topic for which the
2002 Lasker Basic Medical Research
Award was given to James Rothman and
Randy Schekman. Indeed, the work of
Rothman and Schekman on the budding
and NSF/SNAP-dependent fusion of
membrane vesicles in reconstitution sys-
tems and yeast, respectively, was con-
ducted roughly at the same time as the
efforts of Scheller and Su¨dhof. These
complementary approaches interfaced
beautifully such that the results from
Scheller/Su¨dhof informed the work of
Rothman/Schekman and vice versa.
Rapid Progress
Morphological examination of presyn-
aptic terminals and biophysical studies
of synaptic transmission in preparations
such as the squid giant synapse made it
clear that some presynaptic vesicles
were docked at the membrane of special-
ized sites called active zones, the sites at
which neurotransmitter release occurs,
and that the molecular machinery medi-
ating vesicle fusion is likely preassembled1172 Cell 154, September 12, 2013 ª2013 Elto allow the very rapid calcium-dependent
triggering of neurotransmitter release.
Thus, to understand neurotransmitter
release mechanisms required defining
the protein-protein interactions that
mediate these functions. By examining
a protein complex immunoprecipitated
with an antibody to another synaptic
vesicle protein that Su¨dhof had cloned
(Perin et al., 1990), Scheller isolated syn-
taxin, found that it was localized to the
active zone plasma membrane, and pro-
posed that it was involved in synaptic
vesicle docking and/or fusion (Bennett
et al., 1992).
Independently, Rothman and col-
leagues used bovine brain to search for
proteins that were ‘‘receptors’’ for NSF
and SNAPS, essential components of
the intracellular membrane fusion ma-
chinery that he had characterized, and
identified syntaxin and synaptobrevin/
VAMP as well as SNAP-25 as ‘‘SNAREs’’
(an abbreviation for SNAP receptors).
(‘‘SNAP-25’’ is a different protein than
the ‘‘SNAP’’ that partners with NSF.)
Importantly, Rothman found that SNAREs
form a complex, leading to a collaboration
in which Scheller and Rothman demon-
strated that in the absence of NSF and
SNAP, the complex of these three pro-
teins is dissociated by NSF, which acts
as an ATPase (So¨llner et al., 1993). Schel-
ler amplified these results by demon-
strating a direct interaction of syntaxin
with synaptobrevin/VAMP and that multi-sevier Inc.ple syntaxins are expressed in brain and
contribute to the specificity of membrane
fusion in distinct intracellular compart-
ments (Bennett et al., 1993; Scales et al.,
2000). Moreover, in an influential review,
Scheller was the first to clearly describe
the evolutionary conservation of mem-
brane trafficking fusion machinery in all
eukaryotic membrane traffic by com-
paring presynaptic vesicle fusion mecha-
nisms to the results emerging from yeast
and C. elegans genetics (Bennett and
Scheller, 1993).
At the same time, Su¨dhof was making
additional seminal discoveries about the
proteins mediating and regulating presyn-
aptic vesicle fusion. Cesare Montecucco
and Reinhard Jahn had shown, partly in
collaboration with Su¨dhof, that the same
three proteins which were identified as
‘‘SNAREs’’ by Rothman (synaptobrevin/
VAMP, syntaxin, and SNAP-25) were the
targets of botulinum toxins and tetanus
toxin, proteases that dramatically inhibit
neurotransmitter release. These findings
provided compelling evidence that these
SNARE proteins were indeed part of the
core machinery mediating presynaptic
vesicle fusion. Moreover, Su¨dhof discov-
ered Munc18, which he isolated in a tight
complex with syntaxin, and proposed that
Munc18 is an integral component of the
membrane fusion complex together with
the three SNARE proteins (Hata et al.,
1993). This hypothesis was borne out in
subsequent studies demonstrating that
Munc18 was not only required for all
neurotransmitter release but that it was a
founding member of what is now called
the SM protein family for ‘‘Sec1/
Munc18-like proteins,’’ which are essen-
tial for all SNARE-dependent fusion reac-
tions.
Synaptotagmins: Calcium-
Dependent Triggers for Release
Although neurotransmitter release uses a
molecular machinery that is shared with
many other types of intracellular mem-
brane fusion, it is unique in its exquisite
control by calcium. How is it possible for
a rise in calcium to trigger vesicle fusion
in a few hundred microseconds? In an
elegant series of experiments over the
course of two decades, Su¨dhof led the
way in unequivocally demonstrating that
synaptotagmins are the proteins that
bind calcium and trigger the fusion of pre-
synaptic vesicles as well as other cal-
cium-dependent secretory organelles.
The first synaptotagmin was isolated as
a synaptic vesicle antigen termed protein
p65 because its function was unknown. In
1990, Su¨dhof, in collaboration with Rein-
hard Jahn, isolated the cDNA for p65
and deduced that it contained a single
N-terminal transmembrane region, pre-
sumably important for tethering synapto-
tagmin-1 (the now standard name for
p65) to presynaptic vesicles and two
C-terminal calcium-binding C2 domains
(Perin et al., 1990). These C2 domains
resembled sequences in protein kinase
C that had no known function, although
protein kinase C was thought to bind
phospholipids and be activated by cal-
cium. Su¨dhof proceeded to demonstrate
that the C2 domains in synaptotagmin-1
directly bind calcium as well as acidic
phospholipids and later demonstrated
the same for the protein kinase C C2 do-
mains, thus establishing C2 domains as
general calcium-binding domains. He
then had the insight that synaptotagmin-
1 might function as a calcium-activated
bridge that drives final fusion pore open-
ing by tightly connecting docked presyn-
aptic vesicles (via its N-terminal domain)
to phospholipids in the active zone
plasma membrane (via its calcium-acti-
vated C2 domains) (Figure 1B). In the
decade following the cloning of synapto-
tagmin-1, Su¨dhof, in collaboration with
structural biologists such as Jose Rizoand electrophysiologists such as Chuck
Stevens, used an impressive variety of
biochemical and structural techniques to
demonstrate that the C2 domains of
synaptotagmin-1 bind calcium coopera-
tively, form a ternary complex with phos-
pholipid bilayers, and importantly, also
bind SNARE proteins in a calcium-depen-
dent fashion.
While the biochemical and structural
properties of synaptotagmin-1 made it a
very attractive candidate to be the cal-
cium trigger for neurotransmitter release,
both Su¨dhof and Scheller appreciated
that the proof would come from direct
assays of release. In an early experiment,
Scheller found that injecting PC12 cells
with an antibody against synaptotagmin-
1 or a soluble C2-domain-containing pep-
tide fragment inhibited a measure of K+/
calcium-mediated regulated secretion
(Elferink et al., 1993). Su¨dhof took a
comprehensive genetic approach to
elucidate the function of synaptotagmin.
He first demonstrated that knocking out
synaptotagmin-1 was lethal and in cul-
tured neurons caused a dramatic impair-
ment in synaptic transmission, wiping
out fast, synchronous calcium-dependent
neurotransmitter release (Geppert et al.,
1994). In an elegant demonstration of the
power of mouse genetics, he then used
the knowledge gained from his biochem-
ical and structural work to generate a
knockin mouse in which wild-type synap-
totagmin-1 was replaced by synaptotag-
min-1 containing a single point mutation,
which causes a 2-fold decrease in overall
calcium affinity without inducing struc-
tural or conformational changes (Ferna´n-
dez-Chaco´n et al., 2001). Remarkably,
electrophysiological studies of synaptic
transmission in cultured neurons taken
from these mice revealed a 2-fold
decrease in the calcium sensitivity of
neurotransmitter release.
It is nowwell accepted that synaptotag-
mins are the key calcium-dependent
triggers for fast, synchronous neurotrans-
mitter release as well as playing a key role
in calcium-dependent exocytosis from
endocrine cells and many other non-
neuronal cells. Su¨dhof’s genetic experi-
ments also established that synaptotag-
mins act by binding to both SNAREs and
to phospholipids in a calcium-regulated
manner. Synaptotagmins and their inter-
actions are evolutionarily conserved withCell 154, Sepmultiple isoforms found in vertebrates
and invertebrates in which they perform
similar functions. In mammals, there are
16 synaptotagmin isoforms, 8 of which
bind calcium with varying affinities. Syn-
aptotagmin-1, -2 and -9 appear to be
the most important in triggering neuro-
transmitter release at rodent forebrain
synapses, albeit with different kinetics.
The roles of the other synaptotagmins
are an active area of research with one
possibility being that some function in
triggering slower, asynchronous forms of
exocytosis and neurotransmitter release.
Synaptotagmin, however, does not
act alone in the calcium control of mem-
brane fusion. Su¨dhof identified complexin
based on its strong binding to the SNARE
complex (hence the name; McMahon
et al., 1995). Surprisingly, analysis of
complexin-deficient synapses revealed
that it is not essential for fusion itself but
for the calcium-mediated control of fusion
by synaptotagmin (Maximov et al., 2009).
It appears that all forms of synaptotag-
min-dependent exocytosis examined
thus far also require complexin.
Electrophysiological studies of synaptic
transmission following molecular manipu-
lations of complexin and cell fusion
assays reveal that it has two important
functions. It ‘‘clamps’’ the fusion reaction
by preventing complete SNARE complex
assembly until synaptotagmin binds
calcium and simultaneously it is required
for ‘‘activating’’ SNARE complexes before
the final fusion step triggered by the
calcium-dependent activation of synap-
totagmin. One attractive model is that
complexin binds strongly to partially
assembled SNARE complexes at docked
synaptic vesicles, thereby activating
these complexes, and that upon binding
calcium synaptotagmin displaces the
complexin clamp, allowing fusion pore
opening.
Additional Progress
Given the fundamental importance of
neurotransmitter release for brain func-
tion, of course, it is not surprising that
other investigators have made essential
contributions to this topic. Among others,
the work of Reinhard Jahn, Axel Brunger,
and Jose Rizo has led over the last
decade to an exquisitely detailed molecu-
lar model of how SNARE complex for-
mation via the ‘‘zippering’’ of paralleltember 12, 2013 ª2013 Elsevier Inc. 1173
four-helix bundles in the individual SNARE
proteins (one bundle in syntaxin and syn-
aptobrevin, two in SNAP-25) leads to
membrane fusion. Biophysical and imag-
ing studies of neurotransmitter release in
preparations such as cultured neurons
and the calyx of Held have revealed the
recycling of presynaptic vesicles after
they fuse to the plasma membrane and
quantitative estimates of the exact cal-
cium concentrations within nerve termi-
nals that trigger release. In addition, the
molecular composition of active zones,
the specialized sites within presynaptic
terminals at which vesicles dock and
fuse, have been defined and the detailed
functions and interactions of specific pro-
tein components are being elucidated. Of
note is the answer to an old question
raised by the work of Bernard Katz: how
is calcium influx targeted to the presynap-
tic active zone of a nerve terminal? A pro-
tein complex centered on a multidomain
protein called RIM has been identified
that genetic deletion studies suggest
simultaneously tethers calcium channels
to the active zone, docks synaptic vesi-
cles at the active zone, and recruits the
critical priming factor Munc13 to the
active zone (Kaeser et al., 2011). Thus,
we now not only have a molecular frame-
work that accounts for synaptic vesicle
fusion and its control by calcium, but
also an understanding of how calcium is
channeled to the site of vesicle fusion.
All of these advances are in large part a
consequence of the pioneering work of
Scheller and Su¨dhof, who led the way in
successfully dissecting themolecular ma-
chinery of neurotransmitter release.
Concluding Remarks
At a time when funding is tight, and there
is increasing pressure to perform
‘‘applied’’ or ‘‘translational’’ research on
disease models, the Lasker Foundation
is to be congratulated for recognizing1174 Cell 154, September 12, 2013 ª2013 Elthe critical importance of pure basic
research on a fundamental biological
topic. Scheller and Su¨dhof did not set
out to understand a disease but were
fascinated by the molecular basis of
neurotransmitter release. They were
convinced that their efforts would provide
insight into membrane fusion in general
as well as other key aspects of synaptic
function. Furthermore, they knew that
doing the very best basic science would
lead to advances that benefit human
health. Indeed, work on the molecular
mechanisms of neurotransmitter release
has provided insight into the pathophy-
siology of neurodegenerative diseases
such as Parkinson’s and led to the identi-
fication of many additional synaptic pro-
teins that are strongly implicated in the
pathophysiology of complex brain disor-
ders, such as the synaptic cell adhesion
proteins neurexins and neuroligins.
Two lessons, which funding agencies
might note, are that arguably the best pre-
dictor of future success is past success
and that it is often best to fund people,
not detailed projects. Indeed, Scheller
has gone on to huge success as the
leader of Genentech’s research engine
and Su¨dhof continues to make countless
discoveries aiding our understanding of
synaptic function. In today’s world, these
investigators would find it very difficult to
generate the grant support necessary to
take the approaches that garnered them
the Lasker. Thus, their home institutions,
the University of Texas Southwestern
Medical Center and Stanford University
as well as the Howard Hughes Medical
Institute, which supported their efforts,
are also to be congratulated for placing
bets on promising new investigators who
were willing to take the risk of tackling a
new research topic. We should all join in
celebrating this year’s Lasker Basic Med-
ical Research Award winners who now
deservedly join the luminaries who havesevier Inc.shed light on the mystery that is synaptic
transmission.ACKNOWLEDGMENTS
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